Large Cap

Biopharmaceuticals
Biotech
COVID-19
Dividend Stocks
Dividends
Fibonacci Retracement
Fundamental Analysis
Immunology Biopharmaceutical
Large Cap
Pharmaceuticals
Technical Analysis
Vaccines
Value Investing
Value Stocks

JNJ is stabilizing after dropping off a 52-week high – is it a good buy?

Years ago, as I began my career as an investor, I read a book by Peter Lynch. Mr. Lynch had made his name, and his fortune, as the manager of Fidelity’s flagship Magellan fund in the late 70’s and ’80’s, and his incredible performance was one of the big reasons Magellan, at the time, was […]

Read More
Large Cap
Tech Stocks

Big Tech’s Stocks Have Bounced Back. But They’re Not Out of The Woods.

Photo by JOSH EDELSON/AFP via Getty Images The stocks of the five biggest tech companies have mostly recovered from their sharp drop earlier this week, but that doesn’t mean they’re out of the woods. Facebook (FB) plunged nearly 5% on Monday after a whistleblower went public with internal documents and three of its social media […]

Read More

Stocks Set for Massive Gains

X